UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 28, 2023 4:30 P.M.
Form: F-1
CIK: 0001643918
Company Name: Biodexa Pharmaceuticals Plc
File Number: 333-272693